Skip to main content
Log in

The Decision Rules of Cost-Effectiveness Analysis

  • Leading Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

It has become increasingly popular to carry out cost-effectiveness analyses in economic evaluations of healthcare programmes. Cost-effectiveness analysis is based on the maximisation of the health effects for a given amount of resources. However, many published studies fail to report the results of cost-effectiveness analysis in a way that is consistent with this underlying aim. The aim of this article is to demonstrate the decision rules of cost-effectiveness analysis in an easily accessible way for practitioners in the field. A hypothetical example is used to demonstrate the decision rules of cost-effectiveness analysis, and we also show how to estimate the appropriate incremental cost-effectiveness ratios and how to exclude dominated alternatives. It is then shown how fixed budgets or predetermined prices per effectiveness unit can be used as decision rules to maximise health effects and to determine which programmes to implement on the basis of incremental cost-effectiveness ratios. We hope that the article will contribute towards an increased understanding and application of the appropriate decision rules of cost-effectiveness analysis, so that the results of cost-effectiveness analyses can be interpreted meaningfully by decision makers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Weinstein MC, Zeckhauser R. Critical ratios and efficient allocation. J Public Econ 1973; 2: 147–57

    Article  Google Scholar 

  2. Weinstein M. Principles of cost-effective resource allocation in health care organisations. Int J Technol Assess Health Care 1990; 6: 93–105

    Article  PubMed  CAS  Google Scholar 

  3. Karlsson G. Economic evaluation of dental implants [in Swedish]. Linköping Studies in Arts and Science 69. Linköping: Linköping University, 1991

    Google Scholar 

  4. Johannesson M, Weinstein MC. On the decision rules of cost-effectiveness analysis. J Health Econ 1993; 12: 459–67

    Article  PubMed  CAS  Google Scholar 

  5. Sintonen H, Alander V. Comparing the cost-effectiveness of drug regimens in the treatment of duodenal ulcers. J Health Econ 1990; 9: 95–101

    Article  Google Scholar 

  6. Buxton MJ, O’Brien BJ. Economic evaluation of ondansetron: preliminary analysis using clinical trial data prior to price setting. Br J Cancer 1992; 66 Suppl.: S64–7

    Google Scholar 

  7. Garattini L, Grilli R, Scopelliti D, et al. A proposal for Italian guidelines in pharmacoeconomics. PharmacoEconomics 1995; 7: 1–6

    Article  PubMed  CAS  Google Scholar 

  8. Kawachi I, Malcolm LA. The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisal. J Hypertens 1991; 9: 199–208

    Article  PubMed  CAS  Google Scholar 

  9. Johannesson M. The relationship between cost-effectiveness analysis and cost-benefit analysis. Soc Sci Med 1995; 41: 483–9

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karlsson, G., Johannesson, M. The Decision Rules of Cost-Effectiveness Analysis. Pharmacoeconomics 9, 113–120 (1996). https://doi.org/10.2165/00019053-199609020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199609020-00003

Keywords

Navigation